Overall survival rate of patients with T3a and T3b stage prostate... | Download Scientific Diagram
Oncotarget: Melatonin increases overall survival of prostate cancer patients | Oncotarget
Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer - Clinical Genitourinary Cancer
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry | Prostate Cancer and Prostatic Diseases
TITAN trials demonstrates significantly Improved Overall Survival and Radiographic Progression-Free Survival for Apalutamide in Patients with Metastatic Castration-Sensitive Prostate Cancer - Onco Americas
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model - European Urology
ANO7 rs77559646 Is Associated With First-line Docetaxel Treatment Response in Metastatic Castration-resistant Prostate Cancer | Anticancer Research
Comparison of clinical and survival characteristics between prostate cancer patients of PSA-based screening and clinical diagnosis in China | Oncotarget
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry.,Prostate Cancer and Prostatic Diseases - X-MOL
Olaparib for Metastatic Castration-Resistant Prostate Cancer | NEJM
PLOS ONE: Overall survival and second primary malignancies in men with metastatic prostate cancer
Kaplan-Meier analysis of overall survival among prostate cancer... | Download Scientific Diagram
A) Prostate cancer–specific survival and (B) overall survival... | Download Scientific Diagram
The Clinical Efficacy of Enzalutamide in Metastatic Prostate Cancer: Prospective Single-center Study | Anticancer Research
Patients with Localised Prostate Cancer (T1 - T2) Show Improved Overall Long-Term Survival Compared to the Normal Population
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel? - Clinical Genitourinary Cancer
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Association Between Second Progression-free Survival (PFS2) and Overall Survival in Metastatic Castration-resistant Prostate Cancer - European Urology
Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database | Scientific Reports
Recent Advances in the Management of Metastatic Prostate Cancer | JCO Oncology Practice
Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era - International Journal of Radiation Oncology, Biology, Physics
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer - Annals of Oncology
Prognostic factors for overall survival in prostate cancer patients with different site-specific visceral metastases: A study of 1358 patients
